Dusunen Adam-Journal of Psychiatry and Neurological Sciences is a vital resource for scholars and practitioners in the fields of psychiatry and neurology, published by KARE PUBL in Turkey. With an ISSN of 1018-8681 and E-ISSN 1309-5749, this journal has steadily contributed to the academic discourse since its inception, with a dedicated focus on contemporary issues and research findings in psychological and neurological sciences. The journal, which is recognized as Q3 in both the Neurology (clinical) and Psychiatry and Mental Health categories, currently ranks #413 out of 567 in Psychiatry and Mental Health and #298 out of 400 in clinical Neurology according to Scopus. Its commitment to advancing knowledge in these critical areas makes it a significant platform for researchers, professionals, and students alike, fostering a deeper understanding of mental health and neurological disorders that are increasingly relevant in our society. As Dusunen Adam continues to evolve through its convergence years from 2011 to 2024, it remains dedicated to enhancing the quality of life through research and evidence-based practices.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

European Journal of Psychiatry, published by Elsevier España SLU, is a prestigious journal in the field of Psychiatry and Mental Health. Established in 1987, the journal has consistently provided a platform for high-quality research that addresses the complexities of mental health issues. With an impact factor that continues to evolve, it currently holds a significant position within the discipline, ranking Q3 in the 2023 category of Psychiatry and Mental Health. The journal is indexed in Scopus, where it ranks #316/567, placing it in the 44th percentile, affirming its relevance and contribution to the field. Though the journal does not offer open access, it remains a critical resource for researchers, practitioners, and students seeking to stay abreast of pioneering discoveries and methodologies in psychiatry. The European Journal of Psychiatry is a vital link between innovative academic research and practical applications in the mental health sphere, making it an essential resource for advancing knowledge and improving mental health practices.

The American Journal of Psychiatry, published by the renowned American Psychiatric Publishing, Inc., stands as a premier platform in the field of Psychiatry and Mental Health. With its inaugural edition released in 1945, this esteemed journal has consistently provided a wealth of knowledge, shaping the landscape of psychiatric research and practice globally. Notably, in the latest 2023 Scopus rankings, it achieved an impressive rank of #7 out of 567 journals in its category, placing it in the top 2% percentile, indicative of its substantial impact within the field. The journal is committed to publishing high-quality, peer-reviewed original research, clinical studies, and reviews that advance psychiatric knowledge and treatment options. Although it does not currently offer open access, its contributions are vital for researchers, clinicians, and students dedicated to improving mental health care and understanding complex mental health disorders. As an essential resource, it continues to foster scholarly communication among professionals who are at the forefront of psychiatric science.

ACTAS ESPANOLAS DE PSIQUIATRIA, published by the renowned JUAN JOSE LOPEZ-IBOR FOUNDATION, serves as a vital resource in the field of psychiatry and mental health, particularly within the Spanish-speaking academic community. With its ISSN 1139-9287 and E-ISSN 1578-2735, this journal has been a critical platform for disseminating high-quality research since its inception in 1996 and continues to contribute valuable insights until 2024. As a recognized journal in the Q3 category of psychiatry and mental health, it ranks 387 out of 567 in Scopus, placing it within the 31st percentile, thereby indicating a growing influence among its peers. The journal’s open access options enhance its accessibility, encouraging a broader readership to engage with contemporary research issues in mental health. Researchers, professionals, and students alike will find ACTAS ESPANOLAS DE PSIQUIATRIA essential for staying informed on the latest developments and innovations in psychiatric practice and research.

Psychoterapia, published by the Polish Psychiatric Association, is an esteemed academic journal dedicated to the fields of clinical psychology and psychiatry. Established in 2001 and continuing its publication until 2023, this journal serves as a significant platform for the dissemination of research, clinical practices, and theoretical advancements in the realm of mental health. Although it currently holds a Q4 ranking in both the Clinical Psychology and Psychiatry and Mental Health categories, it is committed to improving the understanding and treatment of psychological disorders through rigorous peer-reviewed articles. With its ISSN 0239-4170 and E-ISSN 2391-5862, Psychoterapia provides vital insights that are of interest to researchers, clinicians, and students alike. While the journal does not offer open access options, it remains a recommended resource to further stimulate research and dialogue in the field of psychotherapy.

PERSPECTIVES IN PSYCHIATRIC CARE, published by WILEY, is an esteemed journal that serves as a pivotal resource for researchers, professionals, and students in the realms of psychiatry and mental health. With a history dating back to 1963 and ongoing contributions through 2024, this journal showcases a rich convergence of innovative research and clinical practice. The journal is recognized in prestigious databases with a Scopus rank placing it at #10 out of 45 in the field of Nursing - Psychiatric Mental Health, highlighting its significant influence and relevance. As a Q2 ranked journal in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, it offers a platform for interdisciplinary collaboration and exploration of contemporary issues in mental health care. Although it does not offer open access, PERSPECTIVES IN PSYCHIATRIC CARE provides a comprehensive collection of scholarly articles that advance the field and support best practices in psychiatric care, making it an essential publication for anyone committed to enhancing mental health outcomes.

The British Journal of Psychotherapy is a prestigious journal published by Wiley, focusing on the intricate fields of Clinical Psychology and Psychiatry and Mental Health. Established in 1984, the journal has provided invaluable contributions to the understanding and progression of psychotherapeutic practices, making it a significant resource for researchers, practitioners, and students alike. With an ISSN of 0265-9883 and an E-ISSN of 1752-0118, the journal features a robust selection of articles, reviews, and empirical studies that underscore the latest developments in psychotherapy. Despite its current categorization in the Q3 quartile in both Clinical Psychology and Psychiatry and Mental Health as of 2023, the journal continually strives to enhance its impact and reach within the academic community, reflecting a commitment to advancing knowledge and fostering dialogue in mental health care. For those seeking a comprehensive understanding of contemporary psychotherapeutic methods and research, this journal remains an essential read.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE is a distinguished publication dedicated to advancing the understanding of psychiatric practice and mental health issues within a medical framework. Published by SAGE PUBLICATIONS INC, this journal has been a trusted source in the field since its inception, with its archives dating back to 1973. It offers a comprehensive exploration of psychiatric research, clinical studies, and theoretical advancements that seek to bridge the gap between psychiatry and general medicine. With an impact factor reflective of its quality and relevance, categorized in the Q3 quartile in Psychiatry and Mental Health, this journal stands as a vital resource for researchers, clinicians, and students alike. Although operating on a traditional subscription model, the extensive knowledge shared within its pages contributes significantly to ongoing discussions in psychiatric and mental health education and practice. As the field continually evolves, the INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE remains committed to fostering innovative and impactful scholarship that resonates with professionals navigating the complexities of mental health in clinical contexts.

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.